Executive Team



Anthony H. Cincotta, PhD

President, Chief Science Officer & Founder

Dr. Cincotta is the founder and is responsible for overseeing all research and development. 
He has over 23 successful years in clinical research and development, and is recognized as one of the world's leading authorities on Metabolic Syndrome and Neuroendrocrine Resetting Therapy.


Bindu Chamarthi, MD, MMSc
Medical Director
Dr. Chamarthi is a board certified endocrinologist. She earned her medical degree from Karnatak Medical College (now Karnata Institute of Medical Sciences), India and then completed residency training in Internal Medicine at Boston University and fellowship in Endocrinology, Diabetes and Hypertension at Brigham and Women’s Hospital and Harvard Medical School. She also holds a Masters in Medical Science degree from Harvard Medical School.
Dr. Chamarthi oversees all clinical operations for VeroScience.

Michael Ezrokhi, PhD
Lead Scientist Molecular Biology
Dr. Ezrokhi earned his PhD from Brown University
Dr. Ezrokhi primarily works in the field of Molecular Biology and oversees all research and development in this area.

Shuqin Luo, PhD, MD
Lead Scientist Neuroscience
Dr. Luo earned her PhD from the University of Toronto
Dr. Luo primarily works in the field of Neuroscience and oversees all research and development in this area.

Yahong Zhang, PhD
Lead Scientist Neuroscience
Dr. Zhang earned her PhD degree in neuropharmacology from Loyola University Chicago, IL (2003); served sequentially as a research fellow at Memorial Sloan-Kettering Cancer Center, NY and research associate at Northwestern University joining VeroScience LLC in 2009 as a neuroscientist working on understanding the brain dopaminergic system in the pathogenesis and treatment of metabolic diseases such as type II diabetes.







Clinical Studies
Doctor Info
White Papers

Secure Login